Resultados de la búsqueda 151-160 of 10440 for monoclonal antibody

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

10. Ensayos clínicos - Neurología

    Tumors with high number of mutations may respond well to immunotherapy. Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the ...